The Pulse of New York Tech
Imvax is a biotechnology company which licenses Jefferson systemic cancer immunotherapy technology. Founded by D. Craig Hooper in 2015, Imvax is headquartered in Philadelphia.
WRITE FOR US
NYC TECH EVENTS
NYC TECH NEWS
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.